Annual Net Income:
-$535.60M-$4.16B(-114.80%)Summary
- As of today, VRTX annual net profit is -$535.60 million, with the most recent change of -$4.16 billion (-114.80%) on December 31, 2024.
- During the last 3 years, VRTX annual net income has fallen by -$2.88 billion (-122.87%).
- VRTX annual net income is now -114.80% below its all-time high of $3.62 billion, reached on December 31, 2023.
Performance
VRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$1.03B+$386.60M(+59.82%)Summary
- As of today, VRTX quarterly net profit is $1.03 billion, with the most recent change of +$386.60 million (+59.82%) on June 30, 2025.
- Over the past year, VRTX quarterly net income has increased by +$4.63 billion (+128.74%).
- VRTX quarterly net income is now -32.26% below its all-time high of $1.52 billion, reached on December 31, 2018.
Performance
VRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
$3.64B+$4.63B(+467.84%)Summary
- As of today, VRTX TTM net profit is $3.64 billion, with the most recent change of +$4.63 billion (+467.84%) on June 30, 2025.
- Over the past year, VRTX TTM net income has increased by +$4.13 billion (+842.52%).
- VRTX TTM net income is now -9.50% below its all-time high of $4.02 billion, reached on March 31, 2024.
Performance
VRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VRTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -114.8% | +128.7% | +842.5% |
| 3Y3 Years | -122.9% | +27.4% | +13.9% |
| 5Y5 Years | -145.5% | +23.4% | +35.2% |
VRTX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -114.8% | at low | -6.1% | +128.7% | -9.5% | +467.8% |
| 5Y | 5-Year | -114.8% | at low | -6.1% | +128.7% | -9.5% | +467.8% |
| All-Time | All-Time | -114.8% | +29.0% | -32.3% | +128.7% | -9.5% | +467.8% |
VRTX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.03B(+59.8%) | $3.64B(+467.8%) |
| Mar 2025 | - | $646.30M(-29.2%) | -$988.90M(-84.6%) |
| Dec 2024 | -$535.60M(-114.8%) | $913.00M(-12.7%) | -$535.60M(-11.6%) |
| Sep 2024 | - | $1.05B(+129.1%) | -$479.80M(+2.1%) |
| Jun 2024 | - | -$3.59B(-426.8%) | -$489.90M(-112.2%) |
| Mar 2024 | - | $1.10B(+13.5%) | $4.02B(+11.0%) |
| Dec 2023 | $3.62B(+9.0%) | $968.80M(-6.4%) | $3.62B(+4.3%) |
| Sep 2023 | - | $1.04B(+13.1%) | $3.47B(+3.1%) |
| Jun 2023 | - | $915.70M(+30.9%) | $3.36B(+3.2%) |
| Mar 2023 | - | $699.80M(-14.5%) | $3.26B(-1.9%) |
| Dec 2022 | $3.32B(+41.8%) | $818.90M(-12.0%) | $3.32B(+1.5%) |
| Sep 2022 | - | $930.50M(+14.8%) | $3.27B(+2.5%) |
| Jun 2022 | - | $810.50M(+6.4%) | $3.19B(+30.3%) |
| Mar 2022 | - | $762.10M(-1.0%) | $2.45B(+4.7%) |
| Dec 2021 | $2.34B(-13.6%) | $770.10M(-9.6%) | $2.34B(+7.6%) |
| Sep 2021 | - | $851.93M(+1173.0%) | $2.18B(+9.3%) |
| Jun 2021 | - | $66.92M(-89.8%) | $1.99B(-27.9%) |
| Mar 2021 | - | $653.14M(+8.1%) | $2.76B(+1.9%) |
| Dec 2020 | $2.71B(+130.4%) | $604.19M(-9.5%) | $2.71B(+0.8%) |
| Sep 2020 | - | $667.43M(-20.3%) | $2.69B(+29.3%) |
| Jun 2020 | - | $837.27M(+38.9%) | $2.08B(+37.7%) |
| Mar 2020 | - | $602.75M(+3.3%) | $1.51B(+28.4%) |
| Dec 2019 | $1.18B(-43.6%) | $583.23M(+914.0%) | $1.18B(-44.4%) |
| Sep 2019 | - | $57.52M(-78.5%) | $2.12B(-3.2%) |
| Jun 2019 | - | $267.43M(-0.4%) | $2.19B(+2.9%) |
| Mar 2019 | - | $268.63M(-82.4%) | $2.13B(+2.0%) |
| Dec 2018 | $2.09B(+2184.4%) | $1.52B(+1087.1%) | $2.09B(+214.3%) |
| Sep 2018 | - | $128.44M(-37.7%) | $663.92M(+171.9%) |
| Jun 2018 | - | $206.19M(-9.3%) | $244.22M(+253.0%) |
| Mar 2018 | - | $227.20M(+122.5%) | $69.18M(-24.1%) |
| Dec 2017 | $91.34M(+208.7%) | $102.09M(+135.1%) | $91.12M(+443.0%) |
| Sep 2017 | - | -$291.27M(-1035.2%) | $16.78M(-93.8%) |
| Jun 2017 | - | $31.15M(-87.5%) | $268.51M(+33.4%) |
| Mar 2017 | - | $249.14M(+797.5%) | $201.21M(+339.5%) |
| Dec 2016 | -$84.03M(+85.7%) | $27.76M(+170.2%) | -$84.03M(+55.4%) |
| Sep 2016 | - | -$39.54M(-9.4%) | -$188.24M(+22.4%) |
| Jun 2016 | - | -$36.15M(-0.1%) | -$242.52M(+43.3%) |
| Mar 2016 | - | -$36.10M(+52.8%) | -$427.36M(+27.6%) |
| Dec 2015 | -$588.18M(+20.7%) | -$76.45M(+18.5%) | -$589.96M(+15.0%) |
| Sep 2015 | - | -$93.82M(+57.5%) | -$694.15M(+9.9%) |
| Jun 2015 | - | -$220.99M(-11.2%) | -$770.33M(-8.7%) |
| Mar 2015 | - | -$198.70M(-10.0%) | -$708.72M(+4.5%) |
| Dec 2014 | -$741.83M(-7.9%) | -$180.64M(-6.3%) | -$742.47M(+0.5%) |
| Sep 2014 | - | -$170.00M(-6.7%) | -$746.38M(-5.9%) |
| Jun 2014 | - | -$159.38M(+31.4%) | -$705.05M(-16.1%) |
| Mar 2014 | - | -$232.46M(-26.0%) | -$607.38M(+11.7%) |
| Dec 2013 | -$687.55M(-1244.6%) | -$184.55M(-43.4%) | -$687.55M(-18.3%) |
| Sep 2013 | - | -$128.66M(-108.5%) | -$581.08M(-21.3%) |
| Jun 2013 | - | -$61.71M(+80.3%) | -$478.88M(-6.0%) |
| Mar 2013 | - | -$312.63M(-300.4%) | -$451.64M(-767.9%) |
| Dec 2012 | -$51.13M(-225.1%) | -$78.08M(-195.0%) | -$52.04M(-124.3%) |
| Sep 2012 | - | -$26.47M(+23.2%) | $213.88M(-54.2%) |
| Jun 2012 | - | -$34.47M(-139.6%) | $466.67M(+54.6%) |
| Mar 2012 | - | $86.97M(-53.7%) | $301.82M(+678.8%) |
| Dec 2011 | $40.89M(+105.4%) | $187.85M(-17.0%) | $38.75M(+111.8%) |
| Sep 2011 | - | $226.32M(+213.5%) | -$329.49M(+56.9%) |
| Jun 2011 | - | -$199.32M(-13.2%) | -$764.76M(+0.1%) |
| Mar 2011 | - | -$176.10M(+2.4%) | -$765.45M(-1.4%) |
| Dec 2010 | -$754.63M(-17.5%) | -$180.39M(+13.7%) | -$754.63M(-3.0%) |
| Sep 2010 | - | -$208.96M(-4.5%) | -$732.88M(-8.8%) |
| Jun 2010 | - | -$200.01M(-21.0%) | -$673.49M(-4.5%) |
| Mar 2010 | - | -$165.27M(-4.2%) | -$644.78M(-0.4%) |
| Dec 2009 | -$642.18M(-39.6%) | -$158.64M(-6.1%) | -$642.18M(-2.6%) |
| Sep 2009 | - | -$149.56M(+12.7%) | -$625.87M(-3.2%) |
| Jun 2009 | - | -$171.30M(-5.3%) | -$606.35M(-15.2%) |
| Mar 2009 | - | -$162.67M(-14.3%) | -$526.37M(-14.5%) |
| Dec 2008 | -$459.85M(-17.5%) | -$142.33M(-9.4%) | -$459.85M(-14.0%) |
| Sep 2008 | - | -$130.04M(-42.4%) | -$403.27M(-6.1%) |
| Jun 2008 | - | -$91.32M(+5.0%) | -$380.26M(+6.5%) |
| Mar 2008 | - | -$96.15M(-12.1%) | -$406.70M(-3.9%) |
| Dec 2007 | -$391.28M | -$85.75M(+19.9%) | -$391.28M(-17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$107.03M(+9.1%) | -$332.87M(-19.9%) |
| Jun 2007 | - | -$117.77M(-45.9%) | -$277.64M(-16.9%) |
| Mar 2007 | - | -$80.73M(-195.2%) | -$237.53M(-14.2%) |
| Dec 2006 | -$207.94M(-2.2%) | -$27.34M(+47.2%) | -$207.94M(+4.9%) |
| Sep 2006 | - | -$51.80M(+33.3%) | -$218.72M(+11.3%) |
| Jun 2006 | - | -$77.66M(-51.9%) | -$246.50M(-17.5%) |
| Mar 2006 | - | -$51.13M(-34.1%) | -$209.83M(-3.2%) |
| Dec 2005 | -$203.42M(-22.4%) | -$38.13M(+52.1%) | -$203.42M(+2.2%) |
| Sep 2005 | - | -$79.58M(-94.1%) | -$208.06M(-24.4%) |
| Jun 2005 | - | -$40.99M(+8.3%) | -$167.25M(+1.9%) |
| Mar 2005 | - | -$44.72M(-4.6%) | -$170.53M(-2.6%) |
| Dec 2004 | -$166.25M(+37.6%) | -$42.77M(-10.3%) | -$166.25M(-1.5%) |
| Sep 2004 | - | -$38.77M(+12.4%) | -$163.83M(+22.5%) |
| Jun 2004 | - | -$44.27M(-9.5%) | -$211.48M(+17.8%) |
| Mar 2004 | - | -$40.44M(-0.2%) | -$257.14M(-31.1%) |
| Dec 2003 | -$266.41M(-145.3%) | -$40.35M(+53.3%) | -$196.09M(-4.4%) |
| Sep 2003 | - | -$86.42M(+3.9%) | -$187.82M(-39.3%) |
| Jun 2003 | - | -$89.93M(-536.3%) | -$134.85M(-104.5%) |
| Mar 2003 | - | $20.61M(+164.2%) | -$65.94M(+39.3%) |
| Dec 2002 | -$108.62M(-58.8%) | -$32.08M(+4.1%) | -$108.62M(-20.5%) |
| Sep 2002 | - | -$33.45M(-59.2%) | -$90.14M(-4.9%) |
| Jun 2002 | - | -$21.02M(+4.7%) | -$85.92M(-11.6%) |
| Mar 2002 | - | -$22.07M(-62.3%) | -$77.00M(-20.7%) |
| Dec 2001 | -$68.42M(-87.5%) | -$13.60M(+53.5%) | -$63.81M(-22.0%) |
| Sep 2001 | - | -$29.23M(-141.4%) | -$52.32M(-9.1%) |
| Jun 2001 | - | -$12.11M(-36.5%) | -$47.95M(-106.4%) |
| Mar 2001 | - | -$8.87M(-319.8%) | -$23.23M(+23.9%) |
| Dec 2000 | -$36.50M(+10.9%) | -$2.11M(+91.5%) | -$30.52M(-14.3%) |
| Sep 2000 | - | -$24.86M(-297.1%) | -$26.69M(-65.6%) |
| Jun 2000 | - | $12.61M(+178.1%) | -$16.12M(+59.3%) |
| Mar 2000 | - | -$16.16M(-1042.2%) | -$39.57M(+3.4%) |
| Dec 1999 | -$40.97M(-23.8%) | $1.72M(+112.0%) | -$40.97M(+25.9%) |
| Sep 1999 | - | -$14.29M(-31.8%) | -$55.28M(-27.8%) |
| Jun 1999 | - | -$10.84M(+38.2%) | -$43.27M(-2.5%) |
| Mar 1999 | - | -$17.55M(-39.4%) | -$42.23M(-27.6%) |
| Dec 1998 | -$33.09M(-66.8%) | -$12.60M(-454.2%) | -$33.09M(-21.2%) |
| Sep 1998 | - | -$2.27M(+76.8%) | -$27.29M(+11.7%) |
| Jun 1998 | - | -$9.80M(-16.5%) | -$30.92M(-37.3%) |
| Mar 1998 | - | -$8.41M(-23.7%) | -$22.51M(-13.1%) |
| Dec 1997 | -$19.83M(+50.4%) | -$6.80M(-15.3%) | -$19.90M(-17.1%) |
| Sep 1997 | - | -$5.90M(-321.4%) | -$17.00M(+2.3%) |
| Jun 1997 | - | -$1.40M(+75.9%) | -$17.40M(+54.6%) |
| Mar 1997 | - | -$5.80M(-48.7%) | -$38.30M(+4.3%) |
| Dec 1996 | -$40.01M(-85.8%) | -$3.90M(+38.1%) | -$40.00M(-8.4%) |
| Sep 1996 | - | -$6.30M(+71.7%) | -$36.90M(+1.6%) |
| Jun 1996 | - | -$22.30M(-197.3%) | -$37.50M(-55.0%) |
| Mar 1996 | - | -$7.50M(-837.5%) | -$24.20M(-13.1%) |
| Dec 1995 | -$21.53M(-22.4%) | -$800.00K(+88.4%) | -$21.40M(+16.1%) |
| Sep 1995 | - | -$6.90M(+23.3%) | -$25.50M(-13.3%) |
| Jun 1995 | - | -$9.00M(-91.5%) | -$22.50M(-18.4%) |
| Mar 1995 | - | -$4.70M(+4.1%) | -$19.00M(-8.6%) |
| Dec 1994 | -$17.59M(-963.8%) | -$4.90M(-25.6%) | -$17.50M(-348.7%) |
| Sep 1994 | - | -$3.90M(+29.1%) | -$3.90M(-44.4%) |
| Jun 1994 | - | -$5.50M(-71.9%) | -$2.70M(-235.0%) |
| Mar 1994 | - | -$3.20M(-136.8%) | $2.00M(+5.3%) |
| Dec 1993 | $2.04M(+124.0%) | $8.70M(+422.2%) | $1.90M(+120.0%) |
| Sep 1993 | - | -$2.70M(-237.5%) | -$9.50M(-5.6%) |
| Jun 1993 | - | -$800.00K(+75.8%) | -$9.00M(+10.9%) |
| Mar 1993 | - | -$3.30M(-22.2%) | -$10.10M(-20.2%) |
| Dec 1992 | -$8.49M(-65.0%) | -$2.70M(-22.7%) | -$8.40M(-20.0%) |
| Sep 1992 | - | -$2.20M(-15.8%) | -$7.00M(-16.7%) |
| Jun 1992 | - | -$1.90M(-18.8%) | -$6.00M(-9.1%) |
| Mar 1992 | - | -$1.60M(-23.1%) | -$5.50M(-7.8%) |
| Dec 1991 | -$5.14M(-19.6%) | -$1.30M(-8.3%) | -$5.10M(-4.1%) |
| Sep 1991 | - | -$1.20M(+14.3%) | -$4.90M(-2.1%) |
| Jun 1991 | - | -$1.40M(-16.7%) | -$4.80M(-6.7%) |
| Mar 1991 | - | -$1.20M(-9.1%) | -$4.50M(-4.7%) |
| Dec 1990 | -$4.30M | -$1.10M(0.0%) | -$4.30M(-34.4%) |
| Sep 1990 | - | -$1.10M(0.0%) | -$3.20M(-52.4%) |
| Jun 1990 | - | -$1.10M(-10.0%) | -$2.10M(-110.0%) |
| Mar 1990 | - | -$1.00M | -$1.00M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual net profit?
- What is the all-time high annual net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual net income year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly net profit?
- What is the all-time high quarterly net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly net income year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM net profit?
- What is the all-time high TTM net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM net income year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual net profit?
The current annual net income of VRTX is -$535.60M
What is the all-time high annual net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual net profit is $3.62B
What is Vertex Pharmaceuticals Incorporated annual net income year-on-year change?
Over the past year, VRTX annual net profit has changed by -$4.16B (-114.80%)
What is Vertex Pharmaceuticals Incorporated quarterly net profit?
The current quarterly net income of VRTX is $1.03B
What is the all-time high quarterly net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly net profit is $1.52B
What is Vertex Pharmaceuticals Incorporated quarterly net income year-on-year change?
Over the past year, VRTX quarterly net profit has changed by +$4.63B (+128.74%)
What is Vertex Pharmaceuticals Incorporated TTM net profit?
The current TTM net income of VRTX is $3.64B
What is the all-time high TTM net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM net profit is $4.02B
What is Vertex Pharmaceuticals Incorporated TTM net income year-on-year change?
Over the past year, VRTX TTM net profit has changed by +$4.13B (+842.52%)